Clinical Trial Update: Pharmacogenetics and Cardiovascular Events

View source ↗

Summary

This update reports the completion of an NHLBI-sponsored trial examining pharmacogenetic factors and cardiovascular events across several cardiovascular conditi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Cardiovascular Diseases
• Myocardial Infarction
• Stroke

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Cardiovascular Diseases, Atrial Fibrillation | Status: COMPLETED